Global Albendazole Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Albendazole Market
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

Due to the COVID-19 pandemic, the global Albendazole market size is estimated to be worth US$ 172.6 million in 2022 and is forecast to a readjusted size of US$ 270.8 million by 2028 with a CAGR of 7.8% during the review period. Fully considering the economic change by this health crisis, Tablet accounting for % of the Albendazole global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Human segment is altered to an % CAGR throughout this forecast period.

This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Tablet

Capsule

Other

Segment by Application

Human

Veterinary

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Albendazole market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

GlaxoSmithKline

Huazhong Pharmaceutical

Jiangsu Qihui

Sequent Scientific

K.A. Malle Pharmaceuticals

Lasa Supergenerics Limited

Zhongjia Pharmaceutical

Fredun Pharmaceuticals Ltd

Supharma Chem

Salius Pharma

TABLE OF CONTENT

1 Study Coverage
1.1 Albendazole Product Introduction

1.2 Market by Type

1.2.1 Global Albendazole Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Tablet

1.2.3 Capsule

1.2.4 Other

1.3 Market by Application

1.3.1 Global Albendazole Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Human

1.3.3 Veterinary

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Albendazole Sales Estimates and Forecasts 2017-2028

2.2 Global Albendazole Revenue Estimates and Forecasts 2017-2028

2.3 Global Albendazole Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Albendazole Sales by Region

2.4.1 Global Albendazole Sales by Region (2017-2022)

2.4.2 Global Sales Albendazole by Region (2023-2028)

2.5 Global Albendazole Revenue by Region

2.5.1 Global Albendazole Revenue by Region (2017-2022)

2.5.2 Global Albendazole Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Albendazole Sales by Manufacturers

3.1.1 Global Top Albendazole Manufacturers by Sales (2017-2022)

3.1.2 Global Albendazole Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Albendazole in 2021

3.2 Global Albendazole Revenue by Manufacturers

3.2.1 Global Albendazole Revenue by Manufacturers (2017-2022)

3.2.2 Global Albendazole Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Albendazole Revenue in 2021

3.3 Global Albendazole Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Albendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Albendazole Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Albendazole Sales by Type

4.1.1 Global Albendazole Historical Sales by Type (2017-2022)

4.1.2 Global Albendazole Forecasted Sales by Type (2023-2028)

4.1.3 Global Albendazole Sales Market Share by Type (2017-2028)

4.2 Global Albendazole Revenue by Type

4.2.1 Global Albendazole Historical Revenue by Type (2017-2022)

4.2.2 Global Albendazole Forecasted Revenue by Type (2023-2028)

4.2.3 Global Albendazole Revenue Market Share by Type (2017-2028)

4.3 Global Albendazole Price by Type

4.3.1 Global Albendazole Price by Type (2017-2022)

4.3.2 Global Albendazole Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Albendazole Sales by Application

5.1.1 Global Albendazole Historical Sales by Application (2017-2022)

5.1.2 Global Albendazole Forecasted Sales by Application (2023-2028)

5.1.3 Global Albendazole Sales Market Share by Application (2017-2028)

5.2 Global Albendazole Revenue by Application

5.2.1 Global Albendazole Historical Revenue by Application (2017-2022)

5.2.2 Global Albendazole Forecasted Revenue by Application (2023-2028)

5.2.3 Global Albendazole Revenue Market Share by Application (2017-2028)

5.3 Global Albendazole Price by Application

5.3.1 Global Albendazole Price by Application (2017-2022)

5.3.2 Global Albendazole Price Forecast by Application (2023-2028)

6 North America

6.1 North America Albendazole Market Size by Type

6.1.1 North America Albendazole Sales by Type (2017-2028)

6.1.2 North America Albendazole Revenue by Type (2017-2028)

6.2 North America Albendazole Market Size by Application

6.2.1 North America Albendazole Sales by Application (2017-2028)

6.2.2 North America Albendazole Revenue by Application (2017-2028)

6.3 North America Albendazole Market Size by Country

6.3.1 North America Albendazole Sales by Country (2017-2028)

6.3.2 North America Albendazole Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Albendazole Market Size by Type

7.1.1 Europe Albendazole Sales by Type (2017-2028)

7.1.2 Europe Albendazole Revenue by Type (2017-2028)

7.2 Europe Albendazole Market Size by Application

7.2.1 Europe Albendazole Sales by Application (2017-2028)

7.2.2 Europe Albendazole Revenue by Application (2017-2028)

7.3 Europe Albendazole Market Size by Country

7.3.1 Europe Albendazole Sales by Country (2017-2028)

7.3.2 Europe Albendazole Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Albendazole Market Size by Type

8.1.1 Asia Pacific Albendazole Sales by Type (2017-2028)

8.1.2 Asia Pacific Albendazole Revenue by Type (2017-2028)

8.2 Asia Pacific Albendazole Market Size by Application

8.2.1 Asia Pacific Albendazole Sales by Application (2017-2028)

8.2.2 Asia Pacific Albendazole Revenue by Application (2017-2028)

8.3 Asia Pacific Albendazole Market Size by Region

8.3.1 Asia Pacific Albendazole Sales by Region (2017-2028)

8.3.2 Asia Pacific Albendazole Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Albendazole Market Size by Type

9.1.1 Latin America Albendazole Sales by Type (2017-2028)

9.1.2 Latin America Albendazole Revenue by Type (2017-2028)

9.2 Latin America Albendazole Market Size by Application

9.2.1 Latin America Albendazole Sales by Application (2017-2028)

9.2.2 Latin America Albendazole Revenue by Application (2017-2028)

9.3 Latin America Albendazole Market Size by Country

9.3.1 Latin America Albendazole Sales by Country (2017-2028)

9.3.2 Latin America Albendazole Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Albendazole Market Size by Type

10.1.1 Middle East and Africa Albendazole Sales by Type (2017-2028)

10.1.2 Middle East and Africa Albendazole Revenue by Type (2017-2028)

10.2 Middle East and Africa Albendazole Market Size by Application

10.2.1 Middle East and Africa Albendazole Sales by Application (2017-2028)

10.2.2 Middle East and Africa Albendazole Revenue by Application (2017-2028)

10.3 Middle East and Africa Albendazole Market Size by Country

10.3.1 Middle East and Africa Albendazole Sales by Country (2017-2028)

10.3.2 Middle East and Africa Albendazole Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Corporation Information

11.1.2 GlaxoSmithKline Overview

11.1.3 GlaxoSmithKline Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 GlaxoSmithKline Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 GlaxoSmithKline Recent Developments

11.2 Huazhong Pharmaceutical

11.2.1 Huazhong Pharmaceutical Corporation Information

11.2.2 Huazhong Pharmaceutical Overview

11.2.3 Huazhong Pharmaceutical Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Huazhong Pharmaceutical Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Huazhong Pharmaceutical Recent Developments

11.3 Jiangsu Qihui

11.3.1 Jiangsu Qihui Corporation Information

11.3.2 Jiangsu Qihui Overview

11.3.3 Jiangsu Qihui Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Jiangsu Qihui Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Jiangsu Qihui Recent Developments

11.4 Sequent Scientific

11.4.1 Sequent Scientific Corporation Information

11.4.2 Sequent Scientific Overview

11.4.3 Sequent Scientific Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Sequent Scientific Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sequent Scientific Recent Developments

11.5 K.A. Malle Pharmaceuticals

11.5.1 K.A. Malle Pharmaceuticals Corporation Information

11.5.2 K.A. Malle Pharmaceuticals Overview

11.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 K.A. Malle Pharmaceuticals Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 K.A. Malle Pharmaceuticals Recent Developments

11.6 Lasa Supergenerics Limited

11.6.1 Lasa Supergenerics Limited Corporation Information

11.6.2 Lasa Supergenerics Limited Overview

11.6.3 Lasa Supergenerics Limited Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Lasa Supergenerics Limited Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Lasa Supergenerics Limited Recent Developments

11.7 Zhongjia Pharmaceutical

11.7.1 Zhongjia Pharmaceutical Corporation Information

11.7.2 Zhongjia Pharmaceutical Overview

11.7.3 Zhongjia Pharmaceutical Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Zhongjia Pharmaceutical Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Zhongjia Pharmaceutical Recent Developments

11.8 Fredun Pharmaceuticals Ltd

11.8.1 Fredun Pharmaceuticals Ltd Corporation Information

11.8.2 Fredun Pharmaceuticals Ltd Overview

11.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Fredun Pharmaceuticals Ltd Recent Developments

11.9 Supharma Chem

11.9.1 Supharma Chem Corporation Information

11.9.2 Supharma Chem Overview

11.9.3 Supharma Chem Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Supharma Chem Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Supharma Chem Recent Developments

11.10 Salius Pharma

11.10.1 Salius Pharma Corporation Information

11.10.2 Salius Pharma Overview

11.10.3 Salius Pharma Albendazole Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Salius Pharma Albendazole Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Salius Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Albendazole Industry Chain Analysis

12.2 Albendazole Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Albendazole Production Mode & Process

12.4 Albendazole Sales and Marketing

12.4.1 Albendazole Sales Channels

12.4.2 Albendazole Distributors

12.5 Albendazole Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Albendazole Industry Trends

13.2 Albendazole Market Drivers

13.3 Albendazole Market Challenges

13.4 Albendazole Market Restraints

14 Key Findings in The Global Albendazole Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample